0.00Open0.00Pre Close0 Volume0 Open Interest1000.00Strike Price0.00Turnover7875.79%IV-30.70%PremiumJan 3, 2025Expiry Date234.90Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9871Delta0.0004Gamma--Leverage Ratio-1830.5433Theta0.0000Rho0.00Eff Leverage0.0004Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet